Non-opioid Analgesic Patch Market Research Report by Region (Europe, Asia Pacific, North America and South America), Type and Application, Forecast to 2028 (Updated Version Available)
Non-opioid Analgesic Patch Market Research Report by Region (Europe, Asia Pacific, North America and South America), Type and Application, Forecast to 2028 (Updated Version Available)
ID : MRI40116 | Date : Feb, 2021 | Pages :
180 | Region : Global |
Publisher : 99 Strategy
The Non-opioid Analgesic Patch market report provides a detailed analysis of global market size, value chain optimization, segmentation market growth, market share, competitive Landscape, regional and country-level market size, sales analysis, impact of domestic and global market players, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Non-opioid Analgesic Patch market size is expected to gain market growth in the forecast period of 2023 to 2028, with a CAGR of xx%% in the forecast period of 2023 to 2028 and will expected to reach USD xx million by 2028, from USD xx million in 2020.
Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.
Competitive Landscape and Non-opioid Analgesic Patch Market Share Analysis
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
GlaxoSmithKline Plc
Pfizer, Inc.
Teikoku Seiyaku Co., Ltd.
Mylan N.V.
Hisamitsu Pharmaceutical Co.,Inc
Acorda Therapeutics, Inc
Endo International plc
Allergan
Teh Seng Pharmaceutical Mfg
IBSA Institut Biochimque SA
Product Type Coverage (Market Size Forecast, Major Company of Product Type etc.):
Lidocaine Patches
Diclofenac Patches
Methyl Salicylate Patches
Capsaicin Patches
Ketoprofen Patches
Others
By Application
Hospital Pharmacies
Online Pharmacies
Independent Pharmacies & Drug Stores
Non-opioid Analgesic Patch competitive landscape provides details by vendors, including company overview, company total revenue (financial), market potential, global presence, Non-opioid Analgesic Patch sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Non-opioid Analgesic Patch sales, revenue and market share for each player covered in this report.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Non-opioid Analgesic Patch market presented in the report. This section sheds light on the sales growth of different regional and country-level Non-opioid Analgesic Patch markets. For the historical and forecast period 2015 to 2028, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Non-opioid Analgesic Patch market.
Region Coverage (Regional Production, Demand Forecast by Countries etc.): North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East Africa (Saudi Arabia, South Africa etc.)
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Non-opioid Analgesic Patch market for the forecast period 2023 - 2028?
• What are the driving forces in the Non-opioid Analgesic Patch market for the forecast period 2023 - 2028?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Non-opioid Analgesic Patch industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
CHAPTER 1 MARKET OVERVIEW
1.1 Market Definition and Segment
1.1.1 Product Definition
1.1.2 Product Type
1.1.3 End-Use
1.1.4 Marketing Channel
1.2 Major Regions
1.2.1 Europe Market Size and Growth
Figure Europe Non-opioid Analgesic Patch Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Non-opioid Analgesic Patch Market Forecast and Growth Rate, 2021-2026(Million USD)
1.2.2 America Market Size and Growth
Figure America Non-opioid Analgesic Patch Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Non-opioid Analgesic Patch Market Forecast and Growth Rate, 2021-2026(Million USD)
1.2.3 Asia Market Size and Growth
Figure Asia Non-opioid Analgesic Patch Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaNon-opioid Analgesic Patch Market Forecast and Growth Rate, 2021-2026(Million USD)
1.2.4 Oceania Market Size and Growth
Figure Oceania Non-opioid Analgesic Patch Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Non-opioid Analgesic Patch Market Forecast and Growth Rate, 2021-2026(Million USD)
1.2.5 Africa Market Size and Growth
Figure Africa Non-opioid Analgesic Patch Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Non-opioid Analgesic Patch Market Forecast and Growth Rate, 2021-2026(Million USD)
CHAPTER 2 GLOBAL MARKET SEGMENTATION
2.1 Global Production Overview
Table Global Non-opioid Analgesic Patch Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global Non-opioid Analgesic Patch Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global Non-opioid Analgesic Patch Revenue by Type, 2015-2020 (Million USD)
Figure Global Non-opioid Analgesic Patch Revenue Share by Type in 2020 (Million USD)
Table Global Non-opioid Analgesic Patch Production Volume by Type, 2015-2020 (Volume)
Figure Global Non-opioid Analgesic Patch Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global Non-opioid Analgesic Patch Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Non-opioid Analgesic Patch Consumption Value Share by End-Use in 2020 (Million USD)
Table Global Non-opioid Analgesic Patch Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global Non-opioid Analgesic Patch Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global Non-opioid Analgesic Patch Consumption Value by Region, 2015-2020 (Million USD)
Table Global Non-opioid Analgesic Patch Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 3 Europe MARKET SEGMENTATION
3.1 Europe Production Overview
Table Europe Non-opioid Analgesic Patch Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe Non-opioid Analgesic Patch Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe Non-opioid Analgesic Patch Revenue by Type, 2015-2020 (Million USD)
Figure Europe Non-opioid Analgesic Patch Revenue Share by Type in 2020 (Million USD)
Table Europe Non-opioid Analgesic Patch Production Volume by Type, 2015-2020 (Volume)
Figure Europe Non-opioid Analgesic Patch Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe Non-opioid Analgesic Patch Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Non-opioid Analgesic Patch Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe Non-opioid Analgesic Patch Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe Non-opioid Analgesic Patch Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe Non-opioid Analgesic Patch Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Non-opioid Analgesic Patch Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 4 AMERICA MARKET SEGMENTATION
4.1 America Production Overview
Table America Non-opioid Analgesic Patch Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America Non-opioid Analgesic Patch Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America Non-opioid Analgesic Patch Revenue by Type, 2015-2020 (Million USD)
Figure America Non-opioid Analgesic Patch Revenue Share by Type in 2020 (Million USD)
Table America Non-opioid Analgesic Patch Production Volume by Type, 2015-2020 (Volume)
Figure America Non-opioid Analgesic Patch Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America Non-opioid Analgesic Patch Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Non-opioid Analgesic Patch Consumption Value Share by End-Use in 2020 (Million USD)
Table America Non-opioid Analgesic Patch Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America Non-opioid Analgesic Patch Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America Non-opioid Analgesic Patch Consumption Value by Region, 2015-2020 (Million USD)
Table America Non-opioid Analgesic Patch Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 5 ASIA MARKET SEGMENTATION
5.1 Asia Production Overview
Table Asia Non-opioid Analgesic Patch Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia Non-opioid Analgesic Patch Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia Non-opioid Analgesic Patch Revenue by Type, 2015-2020 (Million USD)
Figure Asia Non-opioid Analgesic Patch Revenue Share by Type in 2020 (Million USD)
Table Asia Non-opioid Analgesic Patch Production Volume by Type, 2015-2020 (Volume)
Figure Asia Non-opioid Analgesic Patch Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia Non-opioid Analgesic Patch Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Non-opioid Analgesic Patch Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia Non-opioid Analgesic Patch Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia Non-opioid Analgesic Patch Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia Non-opioid Analgesic Patch Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Non-opioid Analgesic Patch Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 6 OCEANIA MARKET SEGMENTATION
6.1 Oceania Production Overview
Table Oceania Non-opioid Analgesic Patch Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania Non-opioid Analgesic Patch Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Non-opioid Analgesic Patch Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Non-opioid Analgesic Patch Revenue Share by Type in 2020 (Million USD)
Table Oceania Non-opioid Analgesic Patch Production Volume by Type, 2015-2020 (Volume)
Figure Oceania Non-opioid Analgesic Patch Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania Non-opioid Analgesic Patch Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Non-opioid Analgesic Patch Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania Non-opioid Analgesic Patch Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania Non-opioid Analgesic Patch Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania Non-opioid Analgesic Patch Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Non-opioid Analgesic Patch Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 7 AFRICA MARKET SEGMENTATION
7.1 Africa Production Overview
Table Africa Non-opioid Analgesic Patch Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa Non-opioid Analgesic Patch Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa Non-opioid Analgesic Patch Revenue by Type, 2015-2020 (Million USD)
Figure Africa Non-opioid Analgesic Patch Revenue Share by Type in 2020 (Million USD)
Table Africa Non-opioid Analgesic Patch Production Volume by Type, 2015-2020 (Volume)
Figure Africa Non-opioid Analgesic Patch Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa Non-opioid Analgesic Patch Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Non-opioid Analgesic Patch Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa Non-opioid Analgesic Patch Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa Non-opioid Analgesic Patch Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa Non-opioid Analgesic Patch Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Non-opioid Analgesic Patch Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 8 GLOBAL MARKET FORECAST
8.1 Global Non-opioid Analgesic Patch Production Forecast
Figure Global Non-opioid Analgesic Patch Revenue and Growth Rate Forecast 2021-2026(Million USD)
Figure Global Non-opioid Analgesic Patch Production Volume and Growth Rate Forecast 2021-2026(Volume)
8.2 Global Non-opioid Analgesic Patch Forecast by Type
Table Global Non-opioid Analgesic Patch Revenue by Type, 2021-2026(Million USD)
Figure Global Non-opioid Analgesic Patch Revenue Share by Type in 2026 (Million USD)
Table Global Non-opioid Analgesic Patch Production Volume by Type, 2021-2026(Volume)
Figure Global Non-opioid Analgesic Patch Production Volume Share by Type in 2026 (Volume)
8.3 Global Non-opioid Analgesic Patch Forecast by End-Use (2021E-2026F)
Table Global Non-opioid Analgesic Patch Consumption Value by End-Use, 2021-2026(Million USD)
Figure Global Non-opioid Analgesic Patch Consumption Value Share by End-Use in 2026 (Million USD)
Table Global Non-opioid Analgesic Patch Consumption Volume by End-Use, 2021-2026(Volume)
8.4 Global Non-opioid Analgesic Patch Forecast by Region (2021E-2026F)
Table Global Non-opioid Analgesic Patch Consumption Value by Region, 2021-2026(Million USD)
Figure Global Non-opioid Analgesic Patch Consumption Value Share by Region in 2026 (Million USD)
Table Global Non-opioid Analgesic Patch Consumption Volume by Region, 2021-2026(Volume)
Figure Global Non-opioid Analgesic Patch Consumption Volume Share by Region in 2026 (Volume)
CHAPTER 9 GLOBAL MAJOR COMPANIES LIST
9.1 GlaxoSmithKline Plc
9.1.1 GlaxoSmithKline Plc Profile
Table GlaxoSmithKline Plc Overview List
9.1.2 GlaxoSmithKline Plc Products & Services
9.1.3 GlaxoSmithKline Plc Company Dynamics & News
9.1.4 GlaxoSmithKline Plc Business Operation Conditions
Table Business Operation of GlaxoSmithKline Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 Pfizer, Inc.
9.2.1 Pfizer, Inc. Profile
Table Pfizer, Inc. Overview List
9.2.2 Pfizer, Inc. Products & Services
9.2.3 Pfizer, Inc. Company Dynamics & News
9.2.4 Pfizer, Inc. Business Operation Conditions
Table Business Operation of Pfizer, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 Teikoku Seiyaku Co., Ltd.
9.3.1 Teikoku Seiyaku Co., Ltd. Profile
Table Teikoku Seiyaku Co., Ltd. Overview List
9.3.2 Teikoku Seiyaku Co., Ltd. Products & Services
9.3.3 Teikoku Seiyaku Co., Ltd. Company Dynamics & News
9.3.4 Teikoku Seiyaku Co., Ltd. Business Operation Conditions
Table Business Operation of Teikoku Seiyaku Co., Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 Mylan N.V.
9.4.1 Mylan N.V. Profile
Table Mylan N.V. Overview List
9.4.2 Mylan N.V. Products & Services
9.4.3 Mylan N.V. Company Dynamics & News
9.4.4 Mylan N.V. Business Operation Conditions
Table Business Operation of Mylan N.V. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 Hisamitsu Pharmaceutical Co.,Inc
9.5.1 Hisamitsu Pharmaceutical Co.,Inc Profile
Table Hisamitsu Pharmaceutical Co.,Inc Overview List
9.5.2 Hisamitsu Pharmaceutical Co.,Inc Products & Services
9.5.3 Hisamitsu Pharmaceutical Co.,Inc Company Dynamics & News
9.5.4 Hisamitsu Pharmaceutical Co.,Inc Business Operation Conditions
Table Business Operation of Hisamitsu Pharmaceutical Co.,Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Acorda Therapeutics, Inc
9.6.1 Acorda Therapeutics, Inc Profile
Table Acorda Therapeutics, Inc Overview List
9.6.2 Acorda Therapeutics, Inc Products & Services
9.6.3 Acorda Therapeutics, Inc Company Dynamics & News
9.6.4 Acorda Therapeutics, Inc Business Operation Conditions
Table Business Operation of Acorda Therapeutics, Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 Endo International plc
9.7.1 Endo International plc Profile
Table Endo International plc Overview List
9.7.2 Endo International plc Products & Services
9.7.3 Endo International plc Company Dynamics & News
9.7.4 Endo International plc Business Operation Conditions
Table Business Operation of Endo International plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 Allergan
9.8.1 Allergan Profile
Table Allergan Overview List
9.8.2 Allergan Products & Services
9.8.3 Allergan Company Dynamics & News
9.8.4 Allergan Business Operation Conditions
Table Business Operation of Allergan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 Teh Seng Pharmaceutical Mfg
9.9.1 Teh Seng Pharmaceutical Mfg Profile
Table Teh Seng Pharmaceutical Mfg Overview List
9.9.2 Teh Seng Pharmaceutical Mfg Products & Services
9.9.3 Teh Seng Pharmaceutical Mfg Company Dynamics & News
9.9.4 Teh Seng Pharmaceutical Mfg Business Operation Conditions
Table Business Operation of Teh Seng Pharmaceutical Mfg (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 IBSA Institut Biochimque SA
9.10.1 IBSA Institut Biochimque SA Profile
Table IBSA Institut Biochimque SA Overview List
9.10.2 IBSA Institut Biochimque SA Products & Services
9.10.3 IBSA Institut Biochimque SA Company Dynamics & News
9.10.4 IBSA Institut Biochimque SA Business Operation Conditions
Table Business Operation of IBSA Institut Biochimque SA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
PART 10 MARKET COMPETITION
10.1 Key Company Market Share
Table Global Non-opioid Analgesic Patch Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Non-opioid Analgesic Patch Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Non-opioid Analgesic Patch Sales Volume by Companies, 2015-2020E (Volume)
Table Global Non-opioid Analgesic Patch Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe Non-opioid Analgesic Patch Market Concentration Ratio in 2020E
Figure America Non-opioid Analgesic Patch Market Concentration Ratio in 2020E
Figure Asia Non-opioid Analgesic Patch Market Concentration Ratio in 2020E
Figure Oceania Non-opioid Analgesic Patch Market Concentration Ratio in 2020E
Figure Africa Non-opioid Analgesic Patch Market Concentration Ratio in 2020E
PART 11 CORONAVIRUS IMPACT ON Non-opioid Analgesic Patch INDUSTRY
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
PART 12 Non-opioid Analgesic Patch INDUSTRY SUMMARY & CONCLUSION
Research Methodology
The Market Reports Insights offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.
Market Reports Insights are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
Well researched, expertise analysts, well organized, concrete and current topics delivered in time.
- President and CEO
Very helpful to understand overview of business status, by customers, categories, timeless, and regions. Able to build the future business strategy on the basis of research report. Validated and researched information of reports.
- Senior Manager, Product Development
We are very thankful to (company name) for detailed research report delivering in short period of time. Good market research Company really commendable.
- Senior Manager, Product Development
Excellent services, unique and very professional. The effort taken to make sure relevance to our requirements ensured the best possible outcome.